FUJIFILM Corporation announces that it has entered into a Strategic Alliance Agreement with GE Healthcare. The alliance allows Fujifilm to develop, manufacture and supply advanced biomolecular imaging systems for GE Healthcare. The products, however, will be sold worldwide under the GE brand in the life science research and drug discovery markets. This alliance leverages Fujifilm's strength as a leading device manufacturer and GE's strength as a leading reagent and service provider in the life sciences area. In 1987, Fujifilm was the first company to introduce the revolutionary digital autoradiography device which utilized the Imaging Plate, a radiation detector with sensitivity 100 times greater than X-ray film. In 1923, GE Healthcare introduced the first radio isotope reagents, which initiated the field of biomolecular labeling and detection. FUJIFILM is currently offering scientific imaging systems for chemiluminescent, fluorescent and radioisotopic detection in the life science market. It does not offer reagents/consumables nor applications. The alliance may strengthen Fujifilm's already leading position on medical imaging technologies and device manufacturing.
No comments:
Post a Comment